Upload Button Icon Add office photos
filter salariesFilter salaries by

Bio Nucleus Pharmaceuticals Medical Content Writer salaries in India

Annual salary range
1 - 5 years exp.
₹2.8 Lakhs - ₹3.6 Lakhs
Low Confidence
info icon
Low confidence means that this average salary is based on data that was reported by very few people.
Salary of majority employees
unlock blur
unlock blur

Interested in this particular role?

Salaries in different departments

Healthcare & Life Sciences
Medical Content Writer Salary
1 year exp. (AmbitionBox Estimate)
unlock-blur

₹1 L/yr - ₹1.2 L/yr

Research & Development
Medical Content Writer Salary
5 years exp. (AmbitionBox Estimate)
unlock-blur

₹4.7 L/yr - ₹5.7 L/yr

Last Updated: 14 Mar 2023

Companies similar to Bio Nucleus Pharmaceuticals for Medical Content Writer

Company name Avg Annual Salary Open Jobs
Logo
Neural IT Medical Content Writer Salary

0 - 6 years exp. (28 salaries)

unlock blur

₹2.5 L/yr - ₹3.8 L/yr

arrow icon 6% less
Logo
Practo Medical Content Writer Salary

1 - 3 years exp. (12 salaries)

unlock blur

₹3 L/yr - ₹6.2 L/yr

arrow icon 45% more
Logo
MEDICCA PRESS Medical Content Writer Salary

1 - 7 years exp. (7 salaries)

unlock blur

₹3.3 L/yr - ₹5.5 L/yr

arrow icon 28% more
unlock blur

₹3.9 L/yr - ₹6.3 L/yr

arrow icon 50% more
unlock blur

₹3 L/yr - ₹5.4 L/yr

arrow icon 36% more
Medical Content Writer salary at Bio Nucleus Pharmaceuticals ranges between ₹2.8 Lakhs to ₹3.6 Lakhs per year for employees with experience between 1 year to 5 years. Salary estimates are based on 2 latest salaries received from various employees of Bio Nucleus Pharmaceuticals.

Similar Designation salaries in Bio Nucleus Pharmaceuticals

Senior Content Writer Salary
(AmbitionBox Estimate)
unlock blur
₹4.3 L/yr - ₹5.5 L/yr
Content Writer Salary
(AmbitionBox Estimate)
unlock blur
₹1 L/yr - ₹1.3 L/yr

Tell us how to improve this page.

Bio Nucleus Pharmaceuticals Medical Content Writer salary in India ranges between ₹2.8 Lakhs to ₹3.6 Lakhs. This is an estimate based on latest salaries received from employees of Bio Nucleus Pharmaceuticals.